Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer's disease (AD).

Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer's disease (AD).

Show other versions (1)

<h4>Objective</h4>To investigate the associations of serum DNA methylation levels of chemokine signaling pathway genes with Alzheimer's disease (AD) and mild cognitive impairment (MCI) in elderly people in Xinjiang, China, and to screen out genes whose DNA methylation could distingu...

Full description

Bibliographic Details
Main Authors:	Ting Zou, Xiaohui Zhou, Qinwen Wang, Yongjie Zhao, Meisheng Zhu, Lei Zhang, Wei Chen, Pari Abuliz, Haijun Miao, Keyimu Kabinur, Kader Alimu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0295320&type=printable

Similar Items

Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer’s disease (AD)
by: Ting Zou, et al.
Published: (2023-01-01)

A review: effects of neurofeedback on patients with mild cognitive impairment (MCI), and Alzheimer’s disease (AD)
by: Miyako Tazaki
Published: (2024-02-01)

Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion.
by: Han Li, et al.
Published: (2014-01-01)

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
by: Ye Tao, et al.
Published: (2020-04-01)

Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)
by: Andrea Brugnolo, et al.
Published: (2021-01-01)

Structural and functional magnetic resonance imaging (MRI) in the prediction and characterization of mild cognitive impairment (MCI) and Alzheimer's disease (AD)
by: Zamboni, G
Published: (2012)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
by: Matteo Bauckneht, et al.
Published: (2018-04-01)

The Survey of Serum sTNFR1 Level in Conversion Process from Mild Cognitive Impairment (MCI) to Alzheimer’s Disease (AD (
by: Seyed Mahmoud Tabatabaei, et al.
Published: (2018-01-01)

Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease Dementia (ADD): Using the “Doors and People” Tool to Differentiate between Early aMCI—Late aMCI—Mild ADD Diagnostic Groups
by: Athanasios Chatzikostopoulos, et al.
Published: (2022-07-01)

The epidemiology of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) in community-living seniors: protocol of the MemoVie cohort study, Luxembourg
by: Perquin Magali, et al.
Published: (2012-07-01)

Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study
by: Xi Wang, et al.
Published: (2021-01-01)

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
by: Daniela Bertens, et al.
Published: (2019-08-01)

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
by: Jeffrey Fessel
Published: (2020-01-01)

Risk Factors for Mild Cognitive Impairment (MCI)
by: Andrea Mary Loftus
Published: (2017-09-01)

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
by: Eric D. Anderson, et al.
Published: (2016-01-01)

An MRI-derived definition of MCI-to-AD conversion for long-term, automatic prognosis of MCI patients.
by: Yaman Aksu, et al.
Published: (2011-01-01)

Mild cognitive impairment (MCI) gangguan kognitif ringan
by: Perpustakaan UGM, i-lib
Published: (1999)

Can neurocognitive assessment be a lower-cost substitute for biomarkers in predicting progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD)? A narrative review
by: Lea Daou, et al.
Published: (2023-12-01)

Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression
by: Kedma Anne Lima Gomes Alexandrino, et al.
Published: (2024-01-01)

The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD
by: Richard Mohs, et al.
Published: (2024-01-01)

MCI, en dan? De toekomst van 'mild cognitive impairment'
by: Han F.A. Diesfeldt
Published: (2014-11-01)

Eye tracking function in the early detection of mild cognitive impairment (MCI)
by: Ashkboos akbari, et al.
Published: (2021-02-01)

Problems in Classifying Mild Cognitive Impairment (MCI): One or Multiple Syndromes?
by: María del Carmen Díaz-Mardomingo, et al.
Published: (2017-09-01)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
by: Elena Chipi, et al.
Published: (2019-08-01)

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease
by: Jagan A. Pillai, et al.
Published: (2019-07-01)

Resilience in Mild Cognitive Impairment (MCI): Examining the Level and the Associations of Resilience with Subjective Wellbeing and Negative Affect in Early and Late-Stage MCI
by: Styliani Olympia Tsormpatzoudi, et al.
Published: (2023-09-01)

AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
by: Fei Gao, et al.
Published: (2020-01-01)

The utility of measures of electrophysiological and information processing variability in distinguishing between normal age-related cognitive decline, Subjective Memory Complaint (SMC), Mild Cognitive Impairment (MCI), and Alzheimer's disease (AD)
by: Lawlor Brian, et al.
Published: (2006-02-01)

Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals
by: Federico d'Oleire Uquillas, et al.
Published: (2018-01-01)

DTI measures in crossing-fibre areas: Increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease
by: Douaud, G, et al.
Published: (2011)

DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease.
by: Douaud, G, et al.
Published: (2011)

Behavioral Disorders of Spatial Cognition in Patients with Mild Cognitive Impairment due to Alzheimer’s Disease: Preliminary Findings from the BDSC-MCI Project
by: Davide Maria Cammisuli, et al.
Published: (2024-02-01)

Head injury is associated with tau deposition on PET in MCI and AD patients
by: Shannon L. Risacher, et al.
Published: (2021-01-01)

Added value of amyloid PET in individualized risk predictions for MCI patients
by: Ingrid S. vanMaurik, et al.
Published: (2019-12-01)

Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
by: Victoria M. Pak, et al.
Published: (2020-05-01)

Dysfunctional Incidental Olfaction in Mild Cognitive Impairment (MCI): An Electroencephalography (EEG) Study
by: Cornelia Duregger, et al.
Published: (2011-10-01)

Mild cognitive impairment (MCI) and dementia in a sample of adults in the city of Bogotá
by: Olga Lucia Pedraza, et al.

Memory deficits for facial identity in patients with amnestic mild cognitive impairment (MCI).
by: Egemen Savaskan, et al.
Published: (2018-01-01)

Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
by: Ann J. Jones, et al.
Published: (2017-06-01)

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
by: Usma Munawara, et al.
Published: (2021-06-01)